Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Long-Term Efficacy and Safety of Recombinant Interferon Alpha-2 Vs. Hydroxyurea in Polycythemia Vera: Preliminary Results from the Three-Year Analysis of the Daliah Trial - a Randomized Controlled Phase III Clinical Trial

Blood (2018) 132 (Supplement 1): 580.

https://doi.org/10.1182/blood-2018-99-111255

Published: 2018

Journal Articles

No Development of Neutralizing Antibodies Against Recombinant Interferon-Alpha in Ph-Negative Myeloproliferative Neoplasms - a Prospective Study

Lukas Frans Ocias, Dennis Lund Hansen, Thomas Kielsgaard Kristensen, Karin de Stricker, Daniel El Fassi, MD PhD, Jesper Stentoft, Jørn Starklint, Mikael Frederiksen, Marianne Tang Severinsen, Ole Weis Bjerrum, MD DMSc, Peter Møller, Torben Mourits-Andersen, MD, Ulrik Malthe Overgaard, Hans Carl Hasselbalch, MD Professor, DMSc, Klaus Bendtzen, Thomas Stauffer Larsen, MD PhD

Blood (2015) 126 (23): 5177.

https://doi.org/10.1182/blood.V126.23.5177.5177

Published: 2015

Journal Articles

The Impact of Interferon-alpha2 on HLA-Genes in Patients with Polycythemia Vera and Related Neoplasms

Vibe Skov, MSc, PhD, Caroline H Riley, Mads Thomassen, MSc, PhD, Lasse Kjær, MSc, PhD, Thomas Stauffer Larsen, MD PhD, Morten K Jensen, Ole Weis Bjerrum, MD DMSc, Torben A Kruse, Professor, PhD, Hans Carl Hasselbalch, MD Professor, DMSc

Blood (2015) 126 (23): 4097.

https://doi.org/10.1182/blood.V126.23.4097.4097

Published: 2015

Journal Articles

Safety and Efficacy of Combination Therapy of Interferon-Alpha2 + JAK1-2 Inhibitor in the Philadelphia-Negative Chronic Myeloproliferative Neoplasms. Preliminary Results from the Danish Combi-Trial - an Open Label, Single Arm, Non-Randomized Multicenter Phase II Study

Stine Ulrik Mikkelsen, MD, Lasse Kjær, MSc, PhD, Vibe Skov, MSc, PhD, Mads Emil Bjørn, MD PhDStudent, Christen Lykkegaard Andersen, MD PhD, Ole Weis Bjerrum, MD DMSc, Nana Brochmann, MD PhDStudent, Daniel El Fassi, MD PhD, Torben A Kruse, Professor, PhD, Thomas Stauffer Larsen, MD PhD, Torben Mourits-Andersen, MD, Claus Henrik Nielsen, MD Professor, DMSc, Niels Pallisgaard, MSc, Mads Thomassen, MSc, PhD, Hans Carl Hasselbalch, MD Professor, DMSc

Blood (2015) 126 (23): 824.

https://doi.org/10.1182/blood.V126.23.824.824

Published: 2015

Journal Articles

Bone Marrow Lymphocytic Status during Tyrosine Kinase Inhibitor Therapy and Its Relation to Therapy Response in Chronic Phase Chronic Myeloid Leukemia Patients

Mohamed El Missiry, MD MSc, Shady Adnan, MD MSc, Hanna Rajala, MD PhD, Ahmed Al-Samadi, DDS, PhD, Marja Ekblom, Berit Markevän, MD PhD, Ingbritt Åstrand-Grundström, Maren Wold, Birgitte Ravn Juhl, MD dr.MDsci, Ole Weis Bjerrum, MD DMSc, Inger Haulin, Kimmo Porkka, MD PhD, Ulla Olsson-Strömberg, Henrik Hjorth-Hansen, MD PhD, Satu Mustjoki, MD PhD

Blood (2015) 126 (23): 4027.

https://doi.org/10.1182/blood.V126.23.4027.4027

Published: 2015

Journal Articles

A Novel Immunohistochemical Sequential Multi-Labelling and Erasing Technique Enables Epitope Characterization of Bone Marrow Pericytes In Primary Myelofibrosis

Ann Brinch Madelung, MD, Michael Bzorek, MT, Henrik Bondo, MD, Eva M.K. Zetterberg, MD, PhD, Ole Weis Bjerrum, MD, DMSc, Hans Carl Hasselbalch, MD, DMSc, Stefan Scheding, MD, Elisabeth Ralfkiaer, Prof., MD, DMSc

Blood (2010) 116 (21): 4108.

https://doi.org/10.1182/blood.V116.21.4108.4108

Published: 2010

Journal Articles

Gene Expression Profiling with Principal Component Analysis Depicts the Biological Continuum From Essential Thrombocythemia Over Polycythemia Vera to Myelofibrosis

Vibe Skov, PhD, Thomas Stauffer Larsen, MD, PhD, Mads Thomassen, PhD, Caroline Riley, MD, Morten Krogh Jensen, MD, DMSc, Ole Weis Bjerrum, MD, DMSc, Torben A Kruse, Hans Carl Hasselbalch, MD, DMSc

Blood (2010) 116 (21): 4115.

https://doi.org/10.1182/blood.V116.21.4115.4115

Published: 2010

Journal Articles

High Expression of Carcinoembryonic Antigen-Related Cell Adhesion Molecule(CEACAM) 6 In Primary Myelofibrosis

Hans Carl Hasselbalch, MD, DMSc, Vibe Skov, PhD, Thomas Stauffer Larsen, MD, PhD, Mads Thomassen, PhD, Caroline Riley, MD, Morten Krogh Jensen, MD, DMSc, Ole Weis Bjerrum, MD, DMSc, Torben A Kruse

Blood (2010) 116 (21): 4116.

https://doi.org/10.1182/blood.V116.21.4116.4116

Published: 2010

Journal Articles

Increased Expression of Proteasome-Related Genes In Patients with Primary Myelofibrosis

Vibe Skov, PhD, Thomas Stauffer Larsen, MD, PhD, Mads Thomassen, PhD, Caroline Riley, MD, Morten Krogh Jensen, MD, DMSc, Ole Weis Bjerrum, MD, DMSc, Torben A Kruse, Hans Carl Hasselbalch, MD, DMSc

Blood (2010) 116 (21): 4117.

https://doi.org/10.1182/blood.V116.21.4117.4117

Published: 2010

Journal Articles

Enhanced Gene Expression of EZH2 In Patients with Primary Myelofibrosis

Vibe Skov, PhD, Thomas Stauffer Larsen, MD, PhD, Mads Thomassen, PhD, Caroline Riley, MD, Morten Krogh Jensen, MD, DMSc, Ole Weis Bjerrum, MD, DMSc, Torben A Kruse, Hans Carl Hasselbalch, MD, DMSc

Blood (2010) 116 (21): 4118.

https://doi.org/10.1182/blood.V116.21.4118.4118

Published: 2010

Journal Articles

Increased Gene Expression of Histone Deacetylases In Patients with Philadelphia-Negative Chronic Myeloproliferative Neoplasms

Vibe Skov, PhD, Thomas Stauffer Larsen, MD, PhD, Mads Thomassen, PhD, Caroline Riley, MD, Morten Krogh Jensen, MD, DMSc, Ole Weis Bjerrum, MD, DMSc, Torben A Kruse, Hans Carl Hasselbalch, MD, DMSc

Blood (2010) 116 (21): 4119.

https://doi.org/10.1182/blood.V116.21.4119.4119

Published: 2010

NARROW

Long-Term Efficacy and Safety of Recombinant Interferon Alpha-2 Vs. Hydroxyurea in Polycythemia Vera: Preliminary Results from the Three-Year Analysis of the Daliah Trial - a Randomized Controlled Phase III Clinical Trial

No Development of Neutralizing Antibodies Against Recombinant Interferon-Alpha in Ph-Negative Myeloproliferative Neoplasms - a Prospective Study

The Impact of Interferon-alpha2 on HLA-Genes in Patients with Polycythemia Vera and Related Neoplasms

Safety and Efficacy of Combination Therapy of Interferon-Alpha2 + JAK1-2 Inhibitor in the Philadelphia-Negative Chronic Myeloproliferative Neoplasms. Preliminary Results from the Danish Combi-Trial - an Open Label, Single Arm, Non-Randomized Multicenter Phase II Study

Bone Marrow Lymphocytic Status during Tyrosine Kinase Inhibitor Therapy and Its Relation to Therapy Response in Chronic Phase Chronic Myeloid Leukemia Patients

A Novel Immunohistochemical Sequential Multi-Labelling and Erasing Technique Enables Epitope Characterization of Bone Marrow Pericytes In Primary Myelofibrosis

Gene Expression Profiling with Principal Component Analysis Depicts the Biological Continuum From Essential Thrombocythemia Over Polycythemia Vera to Myelofibrosis

High Expression of Carcinoembryonic Antigen-Related Cell Adhesion Molecule(CEACAM) 6 In Primary Myelofibrosis

Increased Expression of Proteasome-Related Genes In Patients with Primary Myelofibrosis

Enhanced Gene Expression of EZH2 In Patients with Primary Myelofibrosis

Increased Gene Expression of Histone Deacetylases In Patients with Philadelphia-Negative Chronic Myeloproliferative Neoplasms

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only